3-(癸基氧基)-2,7,8-三羟基-(1)苯并吡喃并(5,4,3-cde)(1)苯并吡喃-5,10-二酮 | 110007-19-7

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 单宁
• 中文名称: 3-(癸基氧基)-2,7,8-三羟基-(1)苯并吡喃并(5,4,3-cde)(1)苯并吡喃-5,10-二酮
• 英文名称: 3-O-Decylellagic acid
• 英文别名: 7-decoxy-6,13,14-trihydroxy-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(15),4,6,8(16),11,13-hexaene-3,10-dione
• CAS: 110007-19-7
• 化学式: C₂₄H₂₆O₈
• 分子量: 442.5
• InChiKey: IOLJKBSBRLZDIU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.9
• 重原子数：
  32
• 可旋转键数：
  10
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  123
• 氢给体数：
  3
• 氢受体数：
  8

文献信息

• Nanocapsule containing a bioactive compound, and a method of reducing toxicity resulting from cancer therapy
  申请人：King Abdulaziz University

  公开号：US10251842B1

  公开（公告）日：2019-04-09

  Nanocapsules of bioactive compounds derived from natural products as an adjunct treatment for cancer. Nanocapsules of bioactive compounds showed synergy in the treatment of cancer therapy-induced toxicity.

  从天然产品中提取的生物活性化合物纳米胶囊可作为癌症的辅助疗法。生物活性化合物纳米胶囊在治疗癌症治疗引起的毒性方面显示出协同作用。
• THERAPEUTIC USES OF UROLITHINS
  申请人：The Regents of the University of California

  公开号：EP2068864B1

  公开（公告）日：2017-08-23
• Therapeutic Uses of Urolithins
  申请人：Seeram Navindra P.

  公开号：US20120264819A1

  公开（公告）日：2012-10-18

  The subject invention is drawn to ellagitannin metabolites (e.g., urolithin) that find use in treating or preventing a neoplastic disease in a subject.
• NANOCAPSULE CONTAINING A BIOACTIVE COMPOUND, AND A METHOD OF REDUCING TOXICITY RESULTING FROM CANCER THERAPY
  申请人：King Abdulaziz University

  公开号：US20190125684A1

  公开（公告）日：2019-05-02

  Nanocapsules of bioactive compounds derived from natural products as an adjunct treatment for cancer. Nanocapsules of bioactive compounds showed synergy in the treatment of cancer therapy-induced toxicity.
• US8648112B2
  申请人：——

  公开号：US8648112B2

  公开（公告）日：2014-02-11